Lipoprotein(a) Foundation: Did You Know That 63 Million Americans Have a High Risk of Inherited Cardiovascular Disease and May Not Know It?
Lp(a) Foundation Issues Heart Month Infographic to
Raise Awareness that a Simple Blood Test Could be the First Step in
Preventing up to 120,000 Cardiovascular Events Every Year
SAN CARLOS, Calif.–(BUSINESS WIRE)–Lipoprotein(a) Foundation:
WHAT: |
Lipoprotein(a), also known as Lp(a), is currently the strongest |
|
• It is estimated that 1 in 5 people globally have inherited high |
||
• If an adult has high Lp(a), there is at least a 50% chance of |
||
• Poor lifestyle habits do not contribute to high Lipoprotein(a). |
||
• In the 2013 ACC/AHA Guideline on the Treatment of Blood |
||
WHY: |
Up to 120,000 Lp(a) Related Cardiovascular Events Go Undetected |
|
• Lp(a) concentrations can be measured by a simple blood test, but |
||
• A study recently published in JACC shows that the current |
||
• When you consider 1.5 million cardiovascular events each year in |
||
CALL TO ACTION: |
What Can People Do if They Have a Family History of |
|
• Use the Family |
||
• Talk to your doctor about Lp(a) testing to get an accurate risk |
||
• Support patient advocacy to find a therapy and advocate for more |
||
WHO: |
The following cardiovascular event survivors and cardiovascular |
|
• Sandra Revill Tremulis, Calif-based survivor and founder of |
||
• Lp(a) Foundation Patient Advocates / Survivors in Cities around |
||
• Sotirios (Sam) Tsimikas, MD, Director, Vascular Medicine, |
||
• Amit Khera, MD, MSc, Director of the Preventive Cardiology |
1 Mortensen M, MD, PHD, Afzal S, MD, PHD et al. Primary Prevention with Statins. ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy. Guide Statin Therapy. JACC. |
2 CARDIoGRAMplusC4D Consortium, Deloukas P et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013 Jan;45(1):25-33 |
3 Thanassoulis G. et al. Genetic Associations with Valvular |
4 Nordestgaard F., Chapman J, et al. Lipoprotein(a) as a |
5 CDC reference: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6321a3.htm |
Contacts
Lipoprotein(a) Foundation:
Chris K. Joseph, 510-435-4031
cjoseph@lipoproteinafoundation.org